Skip to main content

Maravai Lifesciences Holdings

Maravai LifeSciences Holdings Inc is an American multinational life sciences enterprise specializing in the production of critical products enabling drug therapies, diagnostics, and vaccine manufacturing, prominently featuring nucleic acid production, protein detection technologies, and biologics safety testing. The company supplies high-purity messenger RNA (mRNA) materials, oligonucleotide synthesis reagents, and enzyme formulations to leading global biopharmaceutical and vaccine developers. Its core business operations encompass life sciences manufacturing, biotechnology reagent synthesis, nucleic acid engineering, and global wholesale distribution. Revenue is derived directly from the global wholesale sale of mRNA raw materials, reagents, and analytical testing services to pharmaceutical enterprises. Maravai LifeSciences holds a pioneering global market position in mRNA vaccine manufacturing inputs and nucleic acid production. The company is headquartered in San Diego, California, United States, and its common stock trades on the Nasdaq Global Select Market.

2 of the funds FundTelligence covers report a position in Maravai Lifesciences Holdings.

Legal name
MARAVAI LIFESCIENCES HOLDINGS INC
Sector
Health Care
Country
United States
Funds holding it
2

Funds holding Maravai Lifesciences Holdings

Loading...